Lineweaver Wealth Advisors LLC lessened its holdings in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 36.0% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 5,221 shares of the medical research company

A mother in Massachusetts is entitled to pursue a new theory of liability against drugmaker Amgen Inc. over the death of her 25-year-old son after he took the company's then-recently approved migraine medication Aimovig in 2018, the First Circuit has found.

Find the latest Amgen Inc. (AMG.DE) stock quote, history, news and other vital information to help you with your stock trading and investing.

Fragasso Financial Advisors Inc increased its stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 21.1% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 14,185 shares of the medical research company

Guggenheim lowered its target from USD 388.00 to USD 378.00 on October 12, 2026. Amgen stock costs E

NorthCrest Asset Manangement LLC lifted its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 64.1% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 120,771 shares of the medical research company

Cantor Fitzgerald set a USD 440 target from USD 400 on October 8, 2026. Amgen stock was EUR 376.93 o

Second-quarter revenue hit USD 10.05 billion versus USD 9.43 billion consensus. Amgen stock stood at

Cantor raised its target to USD 440.00 on October 8, 2026. Amgen stock costs EUR 370.65 on October 1

Amgen stock trades at USD 414.87 versus USD 407.44 in the latest U.S. session. The weekly review tra

Stokes Capital Advisors LLC raised its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 187.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,811 shares of the medical research company

Castle Rock Wealth Management LLC trimmed its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 34.0% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 6,194 shares of the medical research company

Avity Investment Management Inc. lowered its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 8.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 69,958 shares of the medical research company

View the basic AMGN option chain and compare options of Amgen Inc. on Yahoo Finance.

At 10:26 p.m. CEST on October 9, 2026, Lang & Schwarz showed Amgen at EUR 371.15 after-hours, up 3.0

Wedmont Private Capital increased its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 33.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,577 shares of the medical research company